Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metformin: intrinsic vasculoprotective properties.

× No keyword cloud information.

11 in total

1. Unexpected recovery from prolonged hypoglycemic coma: a protective role of metformin?

Authors: Jean-Daniel Lalau; Kamel Masmoudi
Journal: Intensive Care Med Date: 2005-01-28 Impact factor: 17.440

2. Differential effects of metformin on age related comorbidities in older men with type 2 diabetes.

Authors: Chen-Pin Wang; Carlos Lorenzo; Samy L Habib; Booil Jo; Sara E Espinoza
Journal: J Diabetes Complications Date: 2017-01-28 Impact factor: 2.852

3. The protective effects of metformin in an in vitro model of aging 3T3 fibroblast under the high glucose conditions.

Authors: Tugba Soydas; Elif Yaprak Sarac; Suzan Cinar; Sibel Dogan; Seyhun Solakoglu; Matem Tuncdemir; Gonul Kanigur Sultuybek
Journal: J Physiol Biochem Date: 2018-03-06 Impact factor: 4.158

4. Metformin restores endothelial function in aorta of diabetic rats.

Authors: Cristina M Sena; Paulo Matafome; Teresa Louro; Elsa Nunes; Rosa Fernandes; Raquel M Seiça
Journal: Br J Pharmacol Date: 2011-05 Impact factor: 8.739

5. 1,1-Dimethyl-biguanidium(2+) dinitrate.

Authors: Michaela Fridrichová; Ivana Císařová; Ivan Němec
Journal: Acta Crystallogr Sect E Struct Rep Online Date: 2011-12-03

Review 6. Metformin as a cellular protector; a synoptic view of modern evidences.

Authors: Nicolas Wiernsperger
Journal: J Nephropharmacol Date: 2015-01-01

7. Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.

Authors: Yi Yang; Guoguo Jin; Hangfan Liu; Kangdong Liu; Jimin Zhao; Xinhuan Chen; Dongyu Wang; Ruihua Bai; Xiang Li; Yanan Jang; Jing Lu; Ying Xing; Ziming Dong
Journal: Oncotarget Date: 2017-08-18

8. Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.

Authors: Luis Mauro Alvim de Lima; Nicolas Wiernsperger; Luiz Guilherme Kraemer-Aguiar; Eliete Bouskela
Journal: Clinics (Sao Paulo) Date: 2009-05 Impact factor: 2.365

9. Evaluation of the Association Metformin: Plantago ovata Husk in Diabetic Rabbits.

Authors: Raquel Díez-Láiz; Juan J García-Vieitez; M José Diez-Liébana; Matilde Sierra-Vega; Ana M Sahagún-Prieto; Ángela P Calle-Pardo; Nélida Fernández-Martínez
Journal: J Diabetes Res Date: 2015-10-20 Impact factor: 4.011

10. Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice.

Authors: Bart J M Eskens; Coert J Zuurbier; Judith van Haare; Hans Vink; Jurgen W G E van Teeffelen
Journal: Cardiovasc Diabetol Date: 2013-12-05 Impact factor: 9.951